Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Buy
25,087
+925
+4% +$107K 0.55% 56
2025
Q4
$2.54M Sell
24,162
-1,851
-7% -$174K 0.47% 60
2025
Q3
$2.18M Buy
26,013
+550
+2% +$45.3K 0.41% 69
2025
Q2
$2.02M Buy
25,463
+1,680
+7% +$134K 0.41% 67
2025
Q1
$2.13M Buy
23,783
+695
+3% +$64.9K 0.48% 62
2024
Q4
$2.3M Buy
23,088
+708
+3% +$73K 0.5% 57
2024
Q3
$2.54M Buy
22,380
+988
+5% +$117K 0.58% 48
2024
Q2
$2.65M Buy
21,392
+434
+2% +$55.9K 0.66% 48
2024
Q1
$2.77M Buy
20,958
+304
+1% +$37.5K 0.7% 46
2023
Q4
$2.25M Buy
20,654
+888
+4% +$92.2K 0.63% 46
2023
Q3
$2.03M Buy
19,766
+295
+2% +$31.8K 0.62% 47
2023
Q2
$2.25M Buy
19,471
+513
+3% +$58.2K 0.69% 44
2023
Q1
$2.02M Sell
18,958
-3,451
-15% -$373K 0.65% 45
2022
Q4
$2.48M Buy
+22,409
New +$2.29M 0.82% 39

Other funds holding MRK

LMG Wealth Partners's MRK Position: Q1 2026 in Review

LMG Wealth Partners increased its Merck (MRK) stake by 3.8% in Q1 2026, buying an estimated $107K and bringing the position to 25,087 shares worth $3.02M. The position accounts for 0.55% of the portfolio, ranked #56.

LMG Wealth Partners first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • LMG Wealth Partners held 25,087 shares of Merck worth $3.02M as of Q1 2026.
  • LMG Wealth Partners bought 925 Merck shares in Q1 2026, an estimated $107K.
  • Merck made up 0.55% of LMG Wealth Partners's portfolio in Q1 2026, its #56 holding.
  • LMG Wealth Partners first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on LMG Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.